Education Information
1996 - 2000
1996 - 2000Doctorate
Ruprecht-Karls-Universitaet Heidelberg, Seyahat, Turizm Ve Eğlence Hizmetleri, Germany
1993 - 1996
1993 - 1996Postgraduate
Universitaet Kaiserslautern, Biyoloji, Germany
1988 - 1992
1988 - 1992Undergraduate
Hacettepe University, Fen Fakültesi, Turkey
Dissertations
2000
2000Doctorate
Die Wechselwirkung von rekombinantem Hepatitis B Virus X-Protein mit kultivierten Zellen: Steuerung apoptotischer Prozesse 
Ruprecht-Karls-Universitaet Heidelberg, Alman Kanser Araştıma Merkezi, Tümör Virolojisi
1996
1996Postgraduate
Untersuchung der Struktur einer instabilen Region im Chromosom von Streptomyces rimosus R6-501
Universitaet Kaiserslautern, Biyoloji, Genetik
Foreign Languages
B2 Upper Intermediate
B2 Upper IntermediateEnglish
C1 Advanced
C1 AdvancedGerman
Research Areas
Life Sciences
Molecular Biology and Genetics
Genetic Engineering
Moleculer Biology of Cancer
Natural Sciences
Academic Titles / Tasks
2012 - Continues
2012 - ContinuesProfessor
Istanbul University, Onkoloji Enstitüsü, Onkoloji
2007 - 2012
2007 - 2012Associate Professor
Istanbul University, Onkoloji Enstitüsü, Onkoloji
2000 - 2007
2000 - 2007Instructor
Istanbul University, Onkoloji Enstitüsü, Onkoloji
Managerial Experience
2009 - Continues
2009 - ContinuesHead of Department
İstanbul Üniversitesi, Onkoloji Enstitüsü
Non Academic Experience
2006 - Continues
2006 - ContinuesÖğretim Gör.
İstanbul Üniveristesi
2000 - 2006
2000 - 2006Arar. Gör.
İstanbul Üniveristesi
Courses
Advising Theses
Continues
ContinuesPostgraduate
DNA Hasarı Oluşturulan Hücrelerde Aday Histon Metillenmelerinin (H3K9me2, H3K9me3 ve H4K20me3) Global Düzeyde İncelenmesi
Gezer U. (Advisor)
M.Çetinkaya(Student)
2021
2021Postgraduate
Prostat Kanseri Hücrelerinde Aday UzunKodlamayan RNA'ların İncelenmesi
Gezer U. (Advisor)
G.HUSEYNOVA(Student)
2019
2019Doctorate
Meme kanserinde histon 4 lizin 20 üçlü metillenmesinin (h4K20ME3) öneminin araştırılması
Gezer U. (Advisor)
H.IŞIN(Student)
2017
2017Doctorate
Prostat kanserinde prostat kanser antijen 3'ün androjenle ilişkisinin araştırılması
Gezer U. (Advisor)
E.ÖZGÜR(Student)
2017
2017Postgraduate
Sitotoksik ajanlarla muamele edilen MCF-7 meme kanseri hücre hattında bazı kodlamayan RNA'ların hücresel ve eksozomal ifade düzeylerinin incelenmesi
Gezer U. (Advisor)
O.KOLDEMİR(Student)
2016
2016Postgraduate
Prostat kanserinde PCA3 ve USP2A genlerinin ifade düzeylerinin araştırılması
Gezer U. (Advisor)
E.UYSALER(Student)
2015
2015Postgraduate
Prostat kanseri hücrelerinden mikroRNA salınımının in vitro karakterizasyonu
Gezer U. (Advisor)
Z.DUYGU(Student)
2012
2012Postgraduate
DNA Hasarı Oluşum Sürecinde Uzun Kodlamayan RNA’ların İncelenmesi, Haziran 2012
Gezer U. (Advisor)
E.Özgür(Student)
2012
2012Postgraduate
Genotoksik Stres İlişkili Apoptozda miR-34 mikroRNA Gen Ailesi ve Caveolin-1 Gen İfadelerinin İncelenmesi
Gezer U. (Advisor)
U.Mert(Student)
Published journal articles indexed by SCI, SSCI, and AHCI
2024
2024Targeted Sequencing of Human Satellite 2 Repeat Sequences in Plasma cfDNA Reveals Potential Breast Cancer Biomarkers.
Gezer U., Oberhofer A., Worf K., Stoetzer O., Holdenrieder S., Bronkhorst A.
Diagnostics (Basel, Switzerland)
, vol.14, no.6, 2024 (SCI-Expanded)
2024
2024The effect of radiation-induced genotoxic stress on the expression of satellite II and satellite III repeats in breast and colon cancer cells
YILMAZ E., ÖZGÜR E., Gazioglu S., Akbas C., GEZER U., YÖRÜKER E. E.
International Journal of Radiation Research
, vol.22, no.1, pp.91-95, 2024 (SCI-Expanded)
2023
2023miR-145-5p suppresses cell proliferation by targeting <i>IGF1R </i>and <i>NRAS </i>genes in multiple myeloma cells
Kaya M., Suer İ., Ozgur E., Capik O., Karatas O. F., Ozturk Ş., et al.
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI
, vol.48, no.5, pp.563-569, 2023 (SCI-Expanded)
2023
2023Plasma Levels of Kynurenine, Soluble OX40 and Mir-138-5p Are Associated With Tumor-infiltrating Lymphocytes in Colorectal Cancer: An Exploratory Study
Zor D. S., Hakan M. T., Özgür E., Horozoglu C., Yörüker E. E., Kulle C. B., et al.
ANTICANCER RESEARCH
, vol.43, no.7, pp.3281-3288, 2023 (SCI-Expanded)
2022
2022The Clinical Utility of Droplet Digital PCR for Profiling Circulating Tumor DNA in Breast Cancer Patients.
Gezer U., Bronkhorst A. J., Holdenrieder S.
Diagnostics (Basel, Switzerland)
, vol.12, no.12, 2022 (SCI-Expanded)
2022
2022Androgen Receptor Blockade Using Enzalutamide Suppresses Long Non-Coding RNA ARLNC1 in Prostate Cancer Cells.
Huseynova G., Özgür E., Bilgiç Gazioğlu S., Esin Yörüker E. E., Gezer U.
Cell journal
, vol.24, no.12, pp.774-778, 2022 (SCI-Expanded)
2022
2022Effect of Cytotoxic Therapy on ALU Expression is Modulated by Hormonal Status in Patients with Breast Cancer
Özgür E., Ferhatoğlu F., Şen F., Gezer U.
BALKAN MEDICAL JOURNAL
, vol.39, no.6, pp.450-451, 2022 (SCI-Expanded)
2022
2022The Utility of Repetitive Cell-Free DNA in Cancer Liquid Biopsies.
Gezer U., Bronkhorst A. J., Holdenrieder S.
Diagnostics (Basel, Switzerland)
, vol.12, no.6, 2022 (SCI-Expanded)
2021
2021Fragmentation Analysis of Plasma DNA Reveals Its Prognostic Value in Gastric Cancer
YÖRÜKER E. E., ÖZGÜR E., KESKİN M., ÖZGÜR İ., GEZER U.
TURKISH JOURNAL OF GASTROENTEROLOGY
, vol.32, no.9, pp.720-726, 2021 (SCI-Expanded)
2021
2021Satellite 2 repeat DNA in blood plasma as a candidate biomarker for the detection of cancer
Özgür E., Mayer Z., Keskin M., Yörüker E. E., Holdenrieder S., Gezer U.
CLINICA CHIMICA ACTA
, vol.514, pp.74-79, 2021 (SCI-Expanded)
2020
2020Investigation of lncRNA H19 in prostate cancer cells and secreted exosomes upon androgen stimulation or androgen receptor blockage
ÖZGÜR E., GEZER U.
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY
, vol.121, no.5, pp.362-365, 2020 (SCI-Expanded)
2020
2020Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer
Ozgur E., Ferhatoglu F., Sen F., Saip P., Gezer U.
CANCER BIOMARKERS
, vol.27, no.1, pp.11-17, 2020 (SCI-Expanded)
2019
2019Plasma Histone H4 and H4K20 Trimethylation Levels Differ Between Colon Cancer and Precancerous Polyps.
Özgür E., Keskin M., Yörüker E. E., Holdenrieder S., Gezer U.
In vivo (Athens, Greece)
, vol.33, pp.1653-1658, 2019 (SCI-Expanded)
2019
2019Enzalutamide restores the testosterone effect on H19 expression in prostate cancer cells but not in exosomes
ÖZGÜR E., GEZER U.
Turgut Özal Tıp Merkezi Dergisi (E.A İnönü Üniversitesi Tıp Fakültesi Dergisi)
, vol.26, pp.1056-1059, 2019 (SCI-Expanded)
2019
2019Detection of serum protein and circulating mRNA of cMET, HGF EGF and EGFR levels in lung cancer patients to guide individualized therapy
Serilmez M., Ozgur E., Karaman Ş., Gezer U., Duranyildiz D.
CANCER BIOMARKERS
, no.2, pp.177-184, 2019 (SCI-Expanded)
2018
2018Neoadjuvant volumetric modulated arc therapy in rectal cancer and the correlation of pathological response with diffusion-weighted MRI and apoptotic markers.
Gurdal N., Fayda M., ALISHEV N., Bakir B., Tastekin D., Aykan F., et al.
Tumori
, vol.104, pp.266-272, 2018 (SCI-Expanded)
2018
2018Potential of circulating nucleosome-associated histone modifications in cancer
Yoruker E. E., Holdenrieder S., Gezer U.
TRANSLATIONAL CANCER RESEARCH
, vol.7, 2018 (SCI-Expanded)
2017
2017PCA3 Silencing Sensitizes Prostate Cancer Cells to Enzalutamide-mediated Androgen Receptor Blockade
Ozgur E., Celik A. I., Darendeliler E., Gezer U.
ANTICANCER RESEARCH
, vol.37, no.7, pp.3631-3637, 2017 (SCI-Expanded)
2016
2016GAS5 oligonucleotides as therapeutic agents in breast cancer
Fayda M., Gezer U.
TRANSLATIONAL CANCER RESEARCH
, vol.5, 2016 (SCI-Expanded)
2016
2016Blood-based biomarkers for diagnosis, prognosis and treatment of colorectal cancer
Yoruker E. E., Holdenrieder S., Gezer U.
CLINICA CHIMICA ACTA
, vol.455, pp.26-32, 2016 (SCI-Expanded)
2016
2016Do circulating long non-coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) predict the treatment response in patients with head and neck cancer treated with chemoradiotherapy?
Fayda M., Isin M., Tambas M., Guveli M., Meral R., Altun M., et al.
TUMOR BIOLOGY
, vol.37, no.3, pp.3969-3978, 2016 (SCI-Expanded)
2016
2016MicroRNA Expression Profiles in Papillary Thyroid Carcinoma, Benign Thyroid Nodules and Healthy Controls
Yoruker E. E., Terzioglu D., Teksoz S., Uslu F. E., Gezer U., Dalay N.
JOURNAL OF CANCER
, vol.7, no.7, pp.803-809, 2016 (SCI-Expanded)
2015
2015Androgen Stimulation of PCA3 and miR-141 and Their Release from Prostate Cancer Cells
Gezer U., Tiryakioglu D., Bilgin E., Dalay N., Holdenrieder S.
CELL JOURNAL
, vol.16, no.4, pp.488-493, 2015 (SCI-Expanded)
2015
2015Histone Methylation Marks on Circulating Nucleosomes as Novel Blood-Based Biomarker in Colorectal Cancer
Gezer U., Yoruker E. E., Keskin M., Kulle C. B., Dharuman Y., Holdenrieder S.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
, vol.16, no.12, pp.29654-29662, 2015 (SCI-Expanded)
2015
2015Exosomal IncRNA-p21 levels may help to distinguish prostate cancer from benign disease
Isin M., Uysaler E., Ozgur E., Koseoglu H., Sanli O., Yucel O. B., et al.
FRONTIERS IN GENETICS
, vol.6, 2015 (SCI-Expanded)
2015
2015Assessment of circulating serum DNA integrity in colorectal cancer patients.
Yoruker E. E., Ozgur E., Keskin M., Dalay N., Holdenrieder S., Gezer U.
Anticancer research
, vol.35, no.4, pp.2435-40, 2015 (SCI-Expanded)
2015
2015Global quantification of heterochromatin-associated histone methylations in cell lines with differential sensitivity to ionizing radiation
Cetinkaya M., Ozgur E., Dalay N., Gezer U.
ACTA BIOCHIMICA POLONICA
, vol.62, no.2, pp.173-176, 2015 (SCI-Expanded)
2014
2014HISTONE MODIFICATIONS IN CIRCULATING NUCLEOSOMES AS POTENTIAL NEW BIOMARKERS IN CANCER
Gezer U., Yoerueker E. E., Keskin M., Holdenrieder S., Dalay N.
ANTICANCER RESEARCH
, vol.34, no.10, pp.5921-5922, 2014 (SCI-Expanded)
2014
2014Long non-coding RNAs with low expression levels in cells are enriched in secreted exosomes.
Gezer U., Ozgur E., Cetinkaya M., Isin M., Dalay N.
Cell biology international
, vol.38, no.9, pp.1076-9, 2014 (SCI-Expanded)
2014
2014Abundant circulating microRNAs in breast cancer patients fluctuate considerably during neoadjuvant chemotherapy
Gezer U., Keskin S., Igci A., Tukenmez M., Tiryakioglu D., Cetinkaya M., et al.
ONCOLOGY LETTERS
, vol.8, no.2, pp.845-848, 2014 (SCI-Expanded)
2014
2014Increased DNA Integrity in Colorectal Cancer
Leszinski G., LEHNER J., Gezer U., Holdenrieder S.
IN VIVO
, vol.28, no.3, pp.299-303, 2014 (SCI-Expanded)
2014
2014Post-translational Histone Modifications in Circulating Nucleosomes as New Biomarkers in Colorectal Cancer
Gezer U., Holdenrieder S.
IN VIVO
, vol.28, no.3, pp.287-292, 2014 (SCI-Expanded)
2014
2014Investigation of circulating lncRNAs in B-cell neoplasms.
Isin M., Ozgur E., ÇETİN G., Erten N., Aktan M., Gezer U., et al.
Clinica chimica acta; international journal of clinical chemistry
, vol.431, pp.255-9, 2014 (SCI-Expanded)
2014
2014Clinical significance of serum circulating insulin-like growth factor-1 (IGF-1) mRNA in hepatocellular carcinoma
Karabulut S., Duranyildiz D., Tas F., Gezer U., Akyuz F., Serilmez M., et al.
TUMOR BIOLOGY
, vol.35, no.3, pp.2729-2739, 2014 (SCI-Expanded)
2013
2013The predictive and prognostic role of tumoral miRNA expression levels in patients with breast cancer (BC) treated with neoadjuvant chemotherapy (NAC)
ERALP Y., KESKIN S., GEZER U., TUKENMEZ M., MUSLUMANOGLU M. E., DALAY N., et al.
CANCER RESEARCH
, vol.73, 2013 (SCI-Expanded)
2013
2013Differential expression of long non-coding RNAs during genotoxic stress-induced apoptosis in HeLa and MCF-7 cells
Ozgur E., Mert U., Isin M., Okutan M., Dalay N., Gezer U.
CLINICAL AND EXPERIMENTAL MEDICINE
, vol.13, no.2, pp.119-126, 2013 (SCI-Expanded)
2013
2013Differential expression of long non coding RNAs during genotoxic stress induced apoptosis in HeLa and MCF 7 cells
ÖZGÜR E., MERT U., IŞIN M., OKUTAN M., DALAY N., GEZER U.
Clinical and experimental medicine
, vol.13, no.2, pp.119-126, 2013 (SCI-Expanded)
2013
2013Characterization of H3K9me3- and H4K20me3-associated circulating nucleosomal DNA by high-throughput sequencing in colorectal cancer
Gezer U., Ustek D., Yoruker E. E., Cakiris A., Abaci N., LESZINSKI G., et al.
TUMOR BIOLOGY
, vol.34, no.1, pp.329-336, 2013 (SCI-Expanded)
2012
2012Induction of p53-inducible microRNA miR-34 by gamma radiation and bleomycin are different.
MERT U., Ozgür E., TIRYAKIOGLU D., Dalay N., Gezer U.
Frontiers in genetics
, vol.3, pp.220, 2012 (SCI-Expanded)
2012
2012Correlation of histone methyl marks with circulating nucleosomes in blood plasma of cancer patients.
Gezer U., Mert U., Ozgur E., Yoruker E. E., Holdenrieder S., Dalay N.
Oncology letters
, vol.3, no.5, pp.1095-1098, 2012 (SCI-Expanded)
2012
2012Relevance of Histone Marks H3K9me3 and H4K20me3 in Cancer
Leszinski G., Gezer U., Siegele B., Stoetzer O., Holdenrieder S.
ANTICANCER RESEARCH
, vol.32, no.5, pp.2199-2205, 2012 (SCI-Expanded)
2011
2011Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer
Agaoglu F. Y., Kovancilar M., Dizdar Y., Darendeliler E., Holdenrieder S., Dalay N., et al.
TUMOR BIOLOGY
, vol.32, no.3, pp.583-588, 2011 (SCI-Expanded)
2011
2011RELEVANCE OF HISTONE MARKERS H3K9ME3 AND H4K20ME3 IN CANCER DISEASE
Leszinski G., Deligezer U., Siegele B., Holdenrieder S.
ANTICANCER RESEARCH
, vol.31, no.5, pp.1989-1990, 2011 (SCI-Expanded)
2011
2011Testing the putative effect of Dicer-substrate siRNAs in regulating gene expression at transcriptional level
Kovancilar M., Dalay M. N., Deligezer U.
TURKISH JOURNAL OF BIOLOGY
, vol.35, no.4, pp.399-404, 2011 (SCI-Expanded)
2010
2010Post-treatment circulating plasma BMP6 mRNA and H3K27 methylation levels discriminate metastatic prostate cancer from localized disease
Deligezer U., Yaman F., Darendeliler E., Dizdar Y., Holdenrieder S., Kovancilar M., et al.
CLINICA CHIMICA ACTA
, vol.411, pp.1452-1456, 2010 (SCI-Expanded)
2009
2009siRNAs targeted to the CpG island region of the CDKN2A gene cause transcriptional gene silencing
Deligezer U., Kovancılar M., Dalay N.
CANCER RESEARCH
, vol.69, 2009 (SCI-Expanded)
2008
2008Effect of chemotherapy on the integrity of serum DNA in patients with breast cancer.
GEZER U., ERALP Y., AKIŞIK E. E., Akışık E. Z., SAİP P. M., Topuz E., et al.
Annals of Newyork Academy of Science
, vol.1137, pp.175-179, 2008 (SCI-Expanded)
2008
2008Size distribution of circulating cell-free DNA in sera of breast cancer patients in course of adjuvant chemotherapy
GEZER U., ERALP Y., AKIŞIK E. E., Akışık E. Z., SAİP P. M., Topuz E., et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
, vol.46, pp.311-317, 2008 (SCI-Expanded)
2008
2008Effect of adjuvant chemotherapy on integrity of free serum DNA in patients with breast cancer
GEZER U., Eralp Y., Yılmaz E. Z., YÖRÜKER E. E., SAİP P. M., Topuz E., et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
, vol.1137, pp.175-9, 2008 (SCI-Expanded)
2008
2008Sequence-specific histone methylation is detectable on circulating nucleosomes in plasma
Deligezer U., Akisik E. E., Erten N., Dalay N.
CLINICAL CHEMISTRY
, vol.54, no.7, pp.1125-1131, 2008 (SCI-Expanded)
2008
2008Detection of histone methylation on circulating nucleosomes in blood plasma
Deligezer U., Akisik E. E., Erten N., Dalay N.
JOURNAL OF CLINICAL ONCOLOGY
, vol.26, no.15, 2008 (SCI-Expanded)
2008
2008Size distribution of circulating cell-free DNA in sera of breast cancer patients in the course of adjuvant chemotherapy
Deligezer U., Eralp Y., Akisik E. E., Akisik E. Z., Saip P., Topuz E., et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
, vol.46, no.3, pp.311-317, 2008 (SCI-Expanded)
2008
2008Effect of adjuvant chemotherapy on integrity of free serum DNA in patients with breast cancer
Deligezer U., Eralp Y., Akisik E. Z., Akisik E. E., Saip P., Topuz E., et al.
CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V
, vol.1137, pp.175-179, 2008 (SCI-Expanded)
2007
2007Expression of the TRAIL receptors in blood mononuclear cells in leukemia.
GEZER U., DALAY M. N.
PATHOLOGY & ONCOLOGY RESEARCH , vol.13, no.4, pp.290-294, 2007 (SCI-Expanded)
2007
2007Lack of association of XRCC1 codon 399Gln polymorphism with chronic myelogenous leukemia
Deligezer U., Akisik E. E., Dalay N.
ANTICANCER RESEARCH
, vol.27, pp.2453-2456, 2007 (SCI-Expanded)
2007
2007Expression of the TRAIL receptors in blood mononuclear cells in leukemia
Deligezer U., Dalay N.
PATHOLOGY & ONCOLOGY RESEARCH
, vol.13, no.4, pp.290-294, 2007 (SCI-Expanded)
2007
2007A novel application of melting curves: utility of peak area calculation for relative methylation quantification
Deligezer U., Akisik E. E., Dalay N.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
, vol.45, no.7, pp.867-873, 2007 (SCI-Expanded)
2006
2006Methylation of the INK/ARF locus in blood mononuclear cells
GEZER U., ERTEN S. N., AKIŞIK E. E., DALAY M. N.
Annals Hematology , vol.85, pp.102-107, 2006 (SCI-Expanded)
2006
2006MTHFR C677T gene polymorphism in lymphoproliferative diseases
GEZER U., AKIŞIK E. E., AĞAOĞLU F., ERTEN S. N., DALAY M. N.
Journal of Clinical and Laboratory Medicine , vol.20, pp.37-41, 2006 (SCI-Expanded)
2006
2006Circulating fragmented nucleosomal DNA and caspase-3 mRNA in patients with lymphoma and myeloma
GEZER U., ERTEN S. N., YÖRÜKER E. E., DALAY M. N.
EXPERIMENTAL MOLECULAR PATHOLOGY , vol.80, no.1, pp.72-76, 2006 (SCI-Expanded)
2006
2006Circulating fragmented nucleosomal DNA and caspase-3 mRNA in patients with lymphoma and myeloma
Deligezer U., Erten N., Akisik E. E., Dalay N.
EXPERIMENTAL AND MOLECULAR PATHOLOGY
, vol.80, no.1, pp.72-76, 2006 (SCI-Expanded)
2006
2006Methylation of the INK4A/ARF locus in blood mononuclear cells
GEZER U., Erten N., YÖRÜKER E. E., DALAY M. N.
ANNALS OF HEMATOLOGY , vol.85, no.2, pp.102-7, 2006 (SCI-Expanded)
2006
2006Methylation of the INK4A/ARF locus in blood mononuclear cells
Deligezer U., Erten N., Akisik E. E., Dalay N.
ANNALS OF HEMATOLOGY
, vol.85, no.2, pp.102-107, 2006 (SCI-Expanded)
2006
2006MTHFR C677T gene polymorphism in lymphoproliferative diseases
Deligezer U., Akisik E. E., Yaman F., Erten N., Dalay N.
JOURNAL OF CLINICAL LABORATORY ANALYSIS
, vol.20, no.2, pp.37-41, 2006 (SCI-Expanded)
2005
2005Methylation of the INK4A/ARF locus in blood mononuclear cells
GEZER U., ERTEN S. N., YÖRÜKER E. E., DALAY M. N.
ANNALS OF HEMATOLOGY , vol.85, no.2, pp.102-107, 2005 (SCI-Expanded)
2005
2005Homozygosity at the C677T of the MTHFR gene is associated with increased breast cancer risk in the Turkish population
Deligezer U., Akisik E. E., Dalay N.
IN VIVO
, vol.19, no.5, pp.889-893, 2005 (SCI-Expanded)
2004
2004Association of the XRCC1 gene polymorphisms with cancer risk in Turkish breast cancer patients
Deligezer U., Dalay N.
EXPERIMENTAL AND MOLECULAR MEDICINE
, vol.36, no.6, pp.572-575, 2004 (SCI-Expanded)
2004
2004Association of the XRCC1 gene polymorphisms with cancer risk in Turkish breast cancer patients
GEZER U., DALAY M. N.
EXPERIMENTAL MOLECULAR MEDICINE
, vol.36, no.6, pp.572-575, 2004 (SCI-Expanded)
2003
2003Frequent copresence of methylated DNA and fragmented nucleosomal DNA in plasma of lymphoma patients
Deligezer U., Yaman F., Erten N., Dalay N.
CLINICA CHIMICA ACTA
, vol.335, pp.89-94, 2003 (SCI-Expanded)
2003
2003Genotyping of the MTHFR gene polymorphism, C677T in patients with leukemia by melting curve analysis
GEZER U., YÖRÜKER E. E., DALAY M. N.
MOLECULAR DIAGNOSIS , vol.7, pp.181-185, 2003 (SCI-Expanded)
2003
2003Frequent co-presence of methylated DNA and fragmented nuclesomal DNA in plasma of lymphoma patients
GEZER U., AĞAOĞLU F., ERTEN S. N., DALAY M. N.
Clinical Chimica Acat
, vol.335, no.5, pp.89-94, 2003 (SCI-Expanded)
Articles Published in Other Journals
2023
2023EXPRESSION OF ALU REPEAT IN BLOOD PLASMA OF PATIENTS WITH BREAST CANCER DURING NEOADJUVANT CHEMOTHERAPY: AN EXPLORATORY STUDY.
Özgür E., Ferhatoglu F., Sen F., Saip P., Gezer U.
Experimental oncology
, vol.45, no.1, pp.120-124, 2023 (Scopus)
2023
2023Meme Kanserinde PD-1/PD-L1 Hedefli Tedaviler
Özen Eroğlu G., Yaylım İ., Kuruca D. S., Gezer U.
JOURNAL OF MEDICAL SCIENCES
, vol.4, no.2, pp.55-61, 2023 (Scopus)
2022
2022Kan Plazmasında Satellit-2 Tekrar Elementi DNA Dizilerinin Karakterizasyonu
ÖZGÜR E., YILDIZ A., BADEMLER S., GEZER U.
İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi , 2022 (Peer-Reviewed Journal)
2022
2022Combining Histone ELISA and Quantitative PCR Assays to Extract and Quantify Histone Methylation-related Circulating DNA
ÖZGÜR E., YÖRÜKER E. E., KESKİN M., GEZER U.
Namık Kemal Tıp Dergisi
, vol.10, no.1, pp.24-28, 2022 (Peer-Reviewed Journal)
2020
2020Impact of histone methyltransferase SUV420H2 in breast cancer
Isin H., Özgür E., Talu C., Trabulus D., Karaçetin D., Gezer U.
BIOMEDICAL REPORTS
, vol.13, no.4, 2020 (ESCI)
2018
2018Diagnostic and prognostic value of circulating lncRNA H19 in gastric cancer
Yoruker E. E., Keskin M., Kulle C. B., Holdenrieder S., Gezer U.
BIOMEDICAL REPORTS
, vol.9, no.2, pp.181-186, 2018 (ESCI)
2017
2017Accumulation of GAS5 in exosomes is a marker of apoptosis induction
Koldemir O., Ozgur E., Gezer U.
BIOMEDICAL REPORTS
, vol.6, no.3, pp.358-362, 2017 (ESCI)
2015
2015Analysis of circulating microRNAs during adjuvant chemotherapy in patients with luminal A breast cancer
Yoruker E. E., Aydogan F., Gezer U., Saip P., Dalay N.
MOLECULAR AND CLINICAL ONCOLOGY
, vol.3, no.4, pp.954-958, 2015 (ESCI)
2015
2015Analysis of circulating microRNAs during adjuvant chemotherapy in patients with luminal A breast cancer
YÖRÜKER E. E., Aydoğan F., GEZER U., SAİP P. M., Dalay M. N.
MOLECULAR AND CLINICAL ONCOLOGY
, vol.3, pp.954-958, 2015 (ESCI)
2015
2015Analysis of circulating microRNAs during adjuvant chemotherapy in patients with luminal A breast cancer.
YÖRÜKER E. E., AYDOĞAN F., GEZER U., SAİP P. M., DALAY N.
Mol Clin Oncol.
, vol.3, no.4, pp.954-958, 2015 (Peer-Reviewed Journal)
2013
2013miR-141 and miR-375 induction and release are different from PSA mRNA and PCA3 upon androgen stimulation of LNCaP cells.
TIRYAKIOGLU D., Bilgin E., HOLDENRIEDER S., DALAY N., GEZER U.
Biomedical reports
, vol.1, pp.802-806, 2013 (ESCI)
2004
2004Kanser hastalarının serum/plazmalarında tümör-spesifik DNA: kanserin erken tanısında potansiyel önemi
GEZER U.
TÜRK ONKOLOJİ DERGİSİ
, vol.19, pp.37-39, 2004 (ESCI)
Refereed Congress / Symposium Publications in Proceedings
2022
2022Targeted sequencing of human satellite 2 repeat sequences in blood plasma of cancer patients
ÖZGÜR E., Bronkhorst A., Oberhofer A., ARĞA K. Y., Holdenreider S., GEZER U.
The 1st International Basic Oncology Congress, Turkey, 02 June 2022
2020
2020Investigation of miR-145 target genes in multiple myeloma cell lines
Kaya M., SUER İ., KARATAŞ Ö. F., ÖZGÜR E., GEZER U., ÇEFLE K., et al.
V. International Participated Erciyes Medical Genetics Days Congress, Nevşehir, Turkey, 20 - 22 February 2020, vol.2584, pp.37
2019
2019Investigation of miR-34a target genes in multiple myeloma cell lines
Suer İ., Kaya M., Karataş Ö. F., Özgür E., Gezer U., Çefle K., et al.
VII. International Congress of Molecular Medicine, İstanbul, Turkey, 5 - 07 September 2019, pp.141
2017
2017Circulating H4K20me3 and SUV420H2 mRNA in blood plasma of patients with colorectal cancer
YORUKER E. E., ÖZGÜR E., KESKİN M., GEZER U.
10th Internatioanl Syposium of Circulating Nucleic Acids in serum and Plasma, Montpellier, France, 20 - 22 September 2017, pp.32
2017
2017PCA3 Suppresion Enhances The Effect of Androgen Receptor Inhibition in Prostate Cancer Cells.
ÖZGÜR E., GEZER U.
VI. International Congress of Molecular Medicine, İstanbul, Turkey, 22 May - 25 August 2017, pp.0-158
2017
2017Is there a correlation between serum Epstein-Barr virus DNA level and tumor metabolic activity, TNM staging and tumor load in nasopharyngeal cancer patients?
Ahmedova A., Ozkaya B., Tambas M., Gezer U., Ozgur E., Sahin D., et al.
53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, United States Of America, 2 - 07 June 2017, vol.35
2017
2017Treatment response and prognosis according to pre and post treatment Ebstein-Barr virus DNA level in nasopharyngeal carcinoma patients.
Ahmedova A., Ozkaya K., Tambas M., Gezer U., Ozgur E., Sahin D., et al.
53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, United States Of America, 2 - 07 June 2017, vol.35
2018
2018Nazofarenks Kanserli Hastalarda Uzun Kodlanmayan RNA(LNCRNA); (Sözel Bildiri sözlü sunum)
Tambaş M., Işın M., Fayda M., Sakin A., Güveli M., Meral R., et al.
13. Ulusal Radyasyon Onkolojisi Kongresi, 27 nisan-01.mayıs 2018, KKTC, Gazimagusa, Cyprus (Kktc), 27 April - 01 May 2018, vol.1, pp.58
2017
2017Nazofarenks kanserli hastalarda Epstein-Barr Virüsü DNA düzeyinin tedavi cevabı ve prognoz ile ilişkisi
Ahmedova A., Özkaya K., Tambaş M., Gezer U., Özgür E., Şahin D., et al.
Ulusal Kanser Kongresi. 22. Ulusal Kanser Kongresi 19 - 23 Nisan 2017, Antalya, Antalya, Turkey, 19 - 23 April 2017, vol.1, pp.225-226
2017
2017Nazofarenks kanserli hastalarda serum Epstein-Barr virusu DNA duzeyinin tumor metabolik aktivitesi, TNM evresi ve tumor yuku ile korelasyonu var mı?
Altun M., Ahmedova A., Özkaya K., Tambaş M., Gezer U., Özgür E., et al.
Ulusal Kanser Kongresi. 22. Ulusal Kanser Kongresi 19 - 23 Nisan 2017, Antalya, Antalya, Turkey, 19 - 23 April 2017, vol.1, pp.226
2016
2016Evaluation of Circulating Long Non-Coding RNA H9 and Cell-free Nucleosomes in Plasma of Patients with Gastric Cancer
YÖRÜKER E. E., KESKİN M., Koldemir O., KULLE C. B., GEZER U.
The 43rd International Society of Oncology and Biomarkers Annual Congress, Chicago, United States Of America, 1 - 06 September 2016, pp.6
2016
2016Rektum kanserinde neoadj. sib-vmat yanıtının difüzyon MR ve serum apoptoz marker düzeyleri ile değerlendirilmesi
GÜRDAL N., FAYDA E. M., BAKIR B., Alishev N., GEZER U., TAŞTEKİN D., et al.
12. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Turkey, 20 - 24 April 2016, pp.45
2015
2015Neoadjuvant Volumetric Modulated Arc Therapy Simultaneous Integrated Boost (SIB-VMAT) With Concurrent Chemotherapy in Rectal Adenocarcinomas and the Correlation of Pathological Response With Diffusion-Weighted MRI and Apoptotic Markers
Gardal N., Fayda M., Bakir B., Alishev N., Gezer U., Tastekin D., et al.
57th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), San-Antonio, Northern Mariana Islands, 18 - 21 October 2015, vol.93
2015
2015Increased DNA Integrity of Free Serum DNA in Patients with Colorectal Cancer
YÖRÜKER E. E., ÖZGÜR E., KESKİN M., DALAY M. N., GEZER U.
The 42nd Congress of the International Society of Oncology and Biomarkers, Zakopane, Poland, 3 - 07 October 2015, pp.50-51
2015
2015Histone methylation marks in circulating nucleosomes as novel biomarker in colorectal cancer
GEZER U., YÖRÜKER E. E., ÖZGÜR E., KESKİN M., Holdenrieder S.
IX. Circulating Nucleic Acids in Plasma and Serum, Berlin, Germany, 10 - 12 September 2015, pp.47
2014
2014Serbest nükleozom ve DNA bütünlüğü kolorektal kanserleri için bir tarama ve takip yöntemi olarak kullanılabilir mi?
KESKİN M., YÖRÜKER E. E., Karip B., ÖZGÜR E., GEZER U., BULUT M. T., et al.
19. Ulusal Cerrahi Kongresi, Antalya, Turkey, 16 - 20 April 2014, pp.25
2014
2014. The predictive and prognostic role of tumoral miRNA expression levels in patients with breast cancer (BC) treated with neoadjuvant chemotherapy (NAC).
GEZER U.
AACR Annual Meeting 2014, San Diego, United States Of America, 5 - 09 April 2014, pp.73
2014
2014Circulating MicroRNA expression analysis in papillary thyroid carcinoma
YÖRÜKER E. E., Terzioğlu D., TEKSÖZ S., USLU F. E., GEZER U., DALAY M. N.
41 Congress of the International Society of Oncology and Biomarkers, Barselona, Spain, 15 - 18 March 2014, pp.27-28
0
0Circulating Long-none coding RNA (HOTAIR, GAS5, and LyncRNA p-21) levels in patients with nasopharyngeal cancer vs. other inoperable head and neck squamous cell cancer
IŞIN M., FAYDA E. M., Güveli M., TAMBAŞ M., GEZER U., MERAL R., et al.
6th International Congress on Nasopharyngeal carcinoma, Turkey, pp.0-38
2013
2013Opere edilmemiş başboyun skuamoz hucreli kanserli hastalarda plazma uzun kodlamayan rna ifade duzeyleri
IŞIN M., FAYDA M., GÜVELİ M., TAMBAŞ M., GEZER U., MERAL R., et al.
XVII Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2013, pp.379
2012
2012High-throughput sequencing of H3K9me3-and H4K20me3-associated circulating nucleosomal DNA
Gezer U., Ustek D., Yoruker E. E., Cakiris A., Abaci N., Leszinski G., et al.
40th Congress of the International-Society-of-Oncology-and-Biomarkers, Jerusalem, Israel, 13 - 17 October 2012, vol.33, pp.56
2012
2012Expression levels of circulating gas5 and lincrna-p21 in multiple myeloma
Isin M., Ozgur E., Erten N., Gezer U., Dalay N.
40th Congress of the International-Society-of-Oncology-and-Biomarkers, Jerusalem, Israel, 13 - 17 October 2012, vol.33, pp.111
2011
2011Investigation of lncRNAs in chronic lymphocytic leukemia and prostate cancer
IŞIN M., Özgür E., AKTAN M., GEZER U., DALAY M. N.
7th NCRI Cancer Conference, United Kingdom, 1 - 04 November 2011, pp.49
2011
2011Kan plazmasında H3K9me3 ve H4K20me3 ilintili nükleozomal DNA’nın yeni nesil dizileme yöntemiyle karakterizasyonu
Mert U., ÜSTEK D., Özgür E., IŞIN M., DALAY M. N., GEZER U.
XII. Tıbbi Biyoloji ve Genetik Kongresi, Antalya, Turkey, 1 - 04 October 2011
2011
2011Genotoksik stres ilintili apoptozda kodlanmayan RNA analizi
Özgür E., Mert U., IŞIN M., DALAY M. N., GEZER U.
XII. Tıbbi Biyoloji ve Genetik Kongresi, Antalya, Turkey, 1 - 04 October 2011
2011
2011Characterization of H3K9me3- and H4K20me3-associated nucleosomal DNA by high-throughput sequencing in colorectal cancer
GEZER U., ÜSTEK D., AKIŞIK E. E., ÇAKİRİS A., ABACI N., Holdenrieder S., et al.
7th International Conference on Circulating Nucleic Acids in Plasma and Serum, Spain, 1 - 04 October 2011, pp.19
2011
2011Investigation of plasma lncRNA levels in chronic lymphocytic leukemia and multiple myeloma patients
IŞIN M., Özgür E., AKTAN M., ERTEN S. N., GEZER U., DALAY M. N.
7th International Conference on Circulating Nucleic Acids in Plasma and Serum, Spain, 1 - 04 October 2011, pp.19
2011
2011Prostat kanseri hücre soyunda androjen baskılanmasının farklı radyoterapi dozlarında radyoduyarlaştırıcı etkisi: DNA metilasyon analizi
Dağoğlu N., AĞAOĞLU F., Kovancılar M., GEZER U., Mert U., DİZDAR M. Y., et al.
IX. Ulusal Kanser Kongresi,, Antalya, Turkey, 1 - 04 April 2011
2011
2011Kan dolaşımında histon modifikasyonlarının nükleozomlarla korelasyonu
GEZER U., Mert U., AKIŞIK E. E., DALAY M. N.
IX. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2011
2011
2011Prostat kanserli hastaların kan plazmalarında mikroRNA genlerinin incelenmesi
GEZER U., Kovancılar M., AĞAOĞLU F., DİZDAR M. Y., DARENDELİLER M. E., DALAY M. N.
IX. Ulusal Kanser Kongresi,, Antalya, Turkey, 1 - 04 April 2011
2011
2011Genotoksik stres varlığında genomda global DNA metillenme düzeyinin incelenmesi
GEZER U., Özgür E., DALAY M. N.
IX. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2011, pp.351
2011
2011Kronik lenfositik lösemili hastaların plazmalarında serbest kodlamayan RNA’ların araştırılması
IŞIN M., Özgür E., AKTAN M., GEZER U., DALAY M. N.
IX. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2011, pp.376
2009
2009H3K9me3/H4K2Ome3 Ratio in Circulating Nucleosomes as Potential Biomarker for Colorectal Cancer
Deligezer U., Akisik E. Z., Akisik E. E., Kovancilar M., Bugra D., Erten N., et al.
6th International Conference on Circulating Nucleic Acids in Plasma and Serum, Hong Kong, PEOPLES R CHINA, 9 - 11 November 2009, pp.97-103
2010
2010Investigation of miR-21, miR-141 and miR-221 in plasma of patients with prostate cancer
Kovancılar M., AĞAOĞLU F., DİZDAR M. Y., DARENDELİLER M. E., DALAY M. N., GEZER U.
IX Ulusal Tıbbi Genetik Kongresi, İstanbul, Turkey, 1 - 04 December 2010, pp.20
2010
2010Relevance of circulating nucleic acids with epigenetic changes in cancer
GEZER U.
IX Ulusal Tıbbi Genetik Kongresi, İstanbul, Turkey, 1 - 04 December 2010, pp.10
2010
2010Histon modifications in circulating nucleosomes as potential biomarker in cancer
GEZER U., YÖRÜKER E. E., Yılmaz E. Z., Kovancılar M., Buğra D., Holdenrieder S., et al.
38th Meeting of the International Society of Oncology and Biomarkers (ISOBM), Germany, 1 - 04 September 2010, pp.34
2010
2010HISTONE MODIFICATIONS H3K9ME3 AND H4K20ME3 ON CIRCULATING NUCLEOSOMES IN CANCER DISEASE
Leszinski G., Deligezer U., Siegele B., Holdenrieder S.
38th Meeting of the International-Society-of-Oncology-and-BioMarkers (ISOBM), Munchen, Germany, 3 - 08 September 2010, vol.31
2010
2010CIRCULATING PLASMA BMP6 mRNA, CELL-FREE DNA, NUCLEOSOMES AND H3K27 METHYLATION LEVELS IN PROSTATE CANCER
Deligezer U., Yaman F., Darendeliler E., Dizdar Y., Holdenrieder S., Kovancilar M., et al.
38th Meeting of the International-Society-of-Oncology-and-BioMarkers (ISOBM), Munchen, Germany, 3 - 08 September 2010, vol.31
2010
2010HISTON MODIFICATIONS IN CIRCULATING NUCLEOSOMES AS POTENTIAL BIOMARKER IN CANCER
Deligezer U., Akisik E. Z., Akisik E. E., Kovancilar M., Bugra D., Erten N., et al.
38th Meeting of the International-Society-of-Oncology-and-BioMarkers (ISOBM), Munchen, Germany, 3 - 08 September 2010, vol.31
2009
2009H3K9me3/H4K20me3 ratio on circulating nucleosomes as potential biomarker for colorectal cancer
GEZER U., Akışık E. Z., AKIŞIK E. E., Kovancılar M., Buğra D., ERTEN S. N., et al.
6th International Conference on Circulating Nucleic Acids in Plasma and Serum, Hong Kong, 1 - 04 November 2009
2009
2009siRNAs targeted to the CpG island region of the CDKN2A gene cause transcriptional gene silencing
GEZER U., Kovancılar M., DALAY M. N.
2009 AACR Annual Meeting, United States Of America, 1 - 04 April 2009
2009
2009Tümör baskılayıcı genlerin CpG adacıklarına hedeflendirilmiş siRNA’LAR transkripsiyonel gen baskılanmasına yol açmaktadır
GEZER U., Kovancılar M., DALAY M. N.
XVIII. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2009, pp.26
2009
2009Kanserli hastaların periferik dolaşımlarında potansiyel biyomarker olarak histon modifikasyonları
GEZER U., Akışık E. Z., AKIŞIK E. E., Kovancılar M., Buğra D., ERTEN S. N., et al.
XVIII. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2009, pp.26
2009
2009Kolorektal kanserli hastalarda p16 tümör süpressor genindeki promotör metilasyonu ve H3lys9 metilasyonunun araştırılması.
AKIŞIK E. E., Akışık E. Z., GEZER U., Buğra D., YAMANER Y. S., DALAY M. N.
XVIII. ULusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2009, pp.26
2008
2008Detection of histone methylation on circulating nucleosomes in blood plasma.
GEZER U., AKIŞIK E. E., ERTEN S. N., DALAY M. N.
2008 ASCO Annual Meeting, United States Of America, 1 - 04 June 2008
2008
2008Detection of Histone Methylation On Circulating Nuclesomes In Blood Plasma
GEZER U., YÖRÜKER E. E., Erten S., DALAY M. N.
ASCO Annual Meeting, United States Of America, 1 - 04 June 2008, pp.14590
2008
2008Kan plazmasında serbest nükleozom ve DNA arasındaki kantitatif ilişkinin incelenmesi.
GEZER U., AKIŞIK E. E., ERTEN S. N., DALAY M. N.
VIII. Ulusal Tıbbi Genetik Kongresi, Çanakkale, Turkey, 1 - 04 May 2008, pp.204
2007
2007Size distribution o circulating cell-free DNA in sera of breast cancer aptients in course of adjuvant therapy
GEZER U., ERALP Y., AKIŞIK E. E., Akışık E. Z., SAİP P. M., Topuz E., et al.
Symposium on Circulating Nucleic Acids in Plasma Serum-V, Russia, 1 - 04 August 2007, pp.9
2007
2007Size Distrubution Circulating Cell-Free DNA In Sera of Breast Cancer Patients In Course of Adjuvant Therapy
GEZER U., Eralp Y., YÖRÜKER E. E., Yılmaz E. Z., SAİP P. M., Topuz E., et al.
Symposium on Circulating Nucleic Acids in Plasma/Serum -V, Russia, 1 - 04 August 2007, pp.9
2007
2007Plazma DNA bütünlüğünün kanserde biyomarker potansiyeli
GEZER U., AKIŞIK E. E., ERTEN S. N., DALAY M. N.
XVII. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2007, pp.193-194
0
0Plazma Serbest DNA Bütünlüğünün Kanserde Biyomarker Potansiyeli
GEZER U., YÖRÜKER E. E., Erten N., DALAY M. N.
XVII. Ulusal Kanser Kongresi, Antalya, Turkey, pp.193-194
2007
2007Myeloid lösemilerde XRCC1 geni kodon 399 polimorfizminin erime eğrisi analizi ile araştırılması
AKIŞIK E. E., GEZER U., DALAY M. N.
XVII. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2007, pp.194
2006
2006Lösemili hastaların mononükleer hücrelerinde TRAİL reseptör ekspresyonu
GEZER U., DALAY M. N.
VII. Prenatal Tanı ve Tıbbi Genetik Kongresi, Kayseri, Turkey, 1 - 04 April 2006, pp.105
2005
2005Methylation of p16INK4A gene in plasma of patients with multiple myeloma
GEZER U., AKIŞIK E. E., DALAY M. N.
Symposium on Circulating Nucleic Acids in Plasm/Serum-IV, United Kingdom, 1 - 04 September 2005, pp.12
2005
2005Lenfoma ve myelomalı hastaların periferik dolaşımlarında nükleozomal DNA fragmentasyonu ile kaspaz-3 ilişkisi
GEZER U., AKIŞIK E. E., AĞAOĞLU F., ERTEN S. N., DALAY M. N.
XVI. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2005, pp.197-188
2005
2005Hodgkin ve lenfoma ve B hücreli neoplazilerde MTHFR C677T gen polimorfizm dağılımının belirlenmesi
AKIŞIK E. E., GEZER U., AĞAOĞLU F., ERTEN S. N., DALAY M. N.
XVI. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2005, pp.194
2003
2003Türk meme kanserli hastalarda XRCC1 gen polimorfizmi ve kanser riski ile ilişkisi
GEZER U., AKIŞIK E. E., DALAY M. N.
8. Ulusal Tıbbi Biyoloji Kongresi, Adana, Turkey, 1 - 04 September 2003, pp.122
2003
2003Metilentetrahidrofolat redüktaz (MTHFR) gen polimorfizmi ve meme kanseri riski
GEZER U., YAZICI ÖZBEK H., YASASEVER F. V., DALAY M. N.
XV. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2003, pp.186-187
2003
2003Lenfoma hastalarının plazmalarında metilenmiş DNA ve nükleozomal DNA
GEZER U., AĞAOĞLU F., ERTEN S. N., DALAY M. N.
XV. Ulusal Kanser Kongresi, Antalya, Turkey, 1 - 04 April 2003, pp.186
2003
2003HER2, estrogen receptor and methylenetetrahydrofolate gene polymorphisms in breast cancer.
Dalay N., Akisik E., Deligezer U.
26th Annual San Antonio Breast Cancer Symposium, San-Antonio, Northern Mariana Islands, 3 - 06 December 2003, vol.82
Books & Book Chapters
2021
2021Onkolojide Prediktif Biyobelirteçler
Özgür E., Gezer U.
in: Türkiye Klinikleri Klinisyenler İçin Temel Onkoloji, Aktaş Safiye,Alakavuklar Mehmet, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.73-78, 2021
2018
2018Ferroptosis
YÖRÜKER E. E., GEZER U.
in: Apoptosis and Beyond: The Many Ways Cells Die, Radosevich J, Editor, John Wiley & Sons, West Sussex, UK , C, pp.129-144, 2018
2018
2018Ferroptosis
YÖRÜKER E. E., GEZER U.
in: Apoptosis and Beyond: The Many Ways Cells Die, Radosevich J, Editor, John Wiley & Sons, West Sussex, UK , C, pp.129-144, 2018
2018
2018Ferroptosis
YÖRÜKER E. E., GEZER U.
in: Apoptosis and Beyond: The Many Ways Cells Die, Radosevich J, Editor, John Wiley & Sons, West Sussex, UK , C, pp.129-144, 2018
2011
2011H3K9me3/H4K20me3 Ratio in Circulating Nucleosomes as Potential Biomarker for Colorectal Cancer
GEZER U., YÖRÜKER E. E., AKIŞIK E., KOVANCILAR M., BUĞRA D., Holdenrieder S., et al.
in: Circulating Nucleic Acids in Plasma and Serum, Graham PB, Editor, Springer, London/Berlin , Amsterdam, pp.97-103, 2011
Supported Projects
2020 - 2022
2020 - 2022
Prostat kanseri hücrelerinde aday uzun kodlamayan RNAların incelenmesi
Project Supported by Higher Education Institutions
GEZER U. (Executive), HUSEYNOVA G.
2017 - 2020
2017 - 2020
Meme kanseri hücrelerinde SUV420H2 gen baskılanmasının hücre sağkalımı üzerine etkisinin araştırılması
Project Supported by Higher Education Institutions
GEZER U. (Executive), ÖZGÜR E.
2017 - 2018
2017 - 2018
Prostat kanseri hücrelerinde androjen reseptör yolağı ile ilişkili genlerin eksozomal ifade düzeylerinin incelenmesi
Project Supported by Higher Education Institutions
ÖZGÜR E. (Executive), GEZER U.
2017 - 2018
2017 - 2018
Kolorektal kanserli hastaların kan plazmalarında SUV420H2 metiltransferaz ve H4K20me3 metillenme düzeyinde incelenmesi
Project Supported by Higher Education Institutions
GEZER U. (Executive), ÖZGÜR E., YÖRÜKER E. E., KESKİN M.
2015 - 2017
2015 - 2017
Mide Kanserlerinde Tanı ve Tedavi Değerlendirilmesinde Serum Temelli H19, Serbest Nükleozom ve DNA Bütünlüğünün Biyomarker Olarak Değerlendirilmesi
Project Supported by Higher Education Institutions
YÖRÜKER E. E. (Executive), KESKİN M., GEZER U.
2015 - 2017
2015 - 2017
Akciğer Kanserinde LYVE-1'in Önemi
Project Supported by Higher Education Institutions
DURANYILDIZ H. D. (Executive), SERİLMEZ M., OĞUZ SOYDİNÇ H., TAŞ F., GEZER U., KİZİR A.
2016 - 2016
2016 - 2016
Mide kanseri hastalarının plazmalarında H19 ekspresyonu ve serbest nükleozom miktarının değerlendirilmesi
Project Supported by Higher Education Institutions
YÖRÜKER E. E. (Executive), GEZER U., KESKİN M., KOLDEMİR O., KULLE C. B.
2016 - 2016
2016 - 2016
Serbest nükleozomların mide kanseri, inflamasyon ve kontrol grubunda karşılaştırılması
Project Supported by Higher Education Institutions
YÖRÜKER E. E. (Executive), GEZER U.
2014 - 2014
2014 - 2014
Circulating microRNAs in patients with breast cancer during neoadjuvant chemotherapy
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2013 - 2014
2013 - 2014DNA Hasar Ajanlarına Maruz Kalan Kültür Hücrelerinden Eksozom Salgılanmasının Karakterizasyonu
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2013 - 2014
2013 - 2014Histon Modifikasyonlarının ELISA-tabanlı Yöntemle Değerlendirilmesi
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2013 - 2014
2013 - 2014
Prostat Kanseri Hücrelerinden mikroRNA Salınımının in vitro Karakterizasyonu
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2012 - 2014
2012 - 2014Gentoksisk Stres Oluşturulan Hücrelerde Uzun Kodlanmayan RNA Analizi
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2012 - 2014
2012 - 2014Genotoksik stres varlığında miR-34 ifadesinin incelenmesi
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2012 - 2014
2012 - 2014DNA Hasarı Oluşturulan Hücrelerde Uzun Kodlanmayan RNA Analizi
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2012 - 2014
2012 - 2014
Prostat Kanserli Hastaların Plazmalarında mikroRNA-141 Molekülünün Klinik Yararlılığının Araştırılması
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2011 - 2014
2011 - 2014Plazmada RNA bütünlüğünün incelenmesi
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2011 - 2013
2011 - 2013
Kan Plazmasında Histon Metillenme Değişimlerinin KOlorektal Kanseri Öneminin Araştırılması
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2012 - 2012
2012 - 2012High-throughput sequencing of H3K9me3- and H4K20me3-associated circulating nucleosomal DNA
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2011 - 2012
2011 - 2012
Meme Kanserli Hastaların Plazmalarında mikroRNA Analizi
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2011 - 2012
2011 - 2012Genotoksik stres ilişkili apoptozda miR-34 mikroRNA gen ailesi ve caveolin-1 gen ifadelerinin incelenmesi.
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2011 - 2012
2011 - 2012DNA Hasarı Oluşum Sürecinde Uzun Kodlanmayan RNA'ların İncelenmesi.
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2011 - 2012
2011 - 2012Kan Plazmasında Nükleozom Miktarı ile Histon Metillenme Düzeyinin Karşılaştırılması
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2011 - 2011
2011 - 2011
Characterization of H3K9me3- and H4K20me3-associated Circulating Nucleosomal DNA by High-Throughput Sequencing in Colorectal Cancer
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2010 - 2011
2010 - 2011
Kolorektal Kanserli Hastalarin Plazmalarında Histon Metillenme Analizi
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2009 - 2011
2009 - 2011
Anti-Kanser Ajan Bleomisinin Yol Açtığı Genotoksik Stres ve Apoptozda DNA Metillenme ve mikroRNA Analizi
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2009 - 2011
2009 - 2011Kan Plazmasında Histon Metillenme Düzeylerinin Optimize Edilmesi
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2009 - 2011
2009 - 2011
Metastatik Prostat Kanserli Hastaların Plazmalarında mikroRNA Analizi
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2008 - 2011
2008 - 2011
Kolon Kanserli Hastaların Plazmalarında Histon Metilasyon Analizi
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2008 - 2011
2008 - 2011p16INK4A ve p14ARF Tümör Baskılayıcı Genlerin Promotör Bölgelerine RNA Müdahalesi Transkripsiyonel Gen Baskılanmasına Yol Açıyormu?
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2010 - 2010
2010 - 2010
HISTON MODIFICATIONS IN CIRCULATING NUCLEOSOMES AS POTENTIAL BIOMARKER IN CANCER
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2009 - 2009
2009 - 2009
H3K9me3/H4K20me3 ratio on circulating nucleosomes as potential biomarker for colorectal cancer
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2008 - 2009
2008 - 2009Plazma DNA'sı Heterokromatik Genom Bölgelerinde Histon Metilasyon Analizi
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2008 - 2009
2008 - 2009
Serum/Plazmada Histon Modifikasyonlarının Kanser Özgüllüğünün Araştırılması
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2008 - 2009
2008 - 2009
Kanserli Hastaların Plazmalarında Nükleozomal DNA ile Serbest DNA Bütünlüğü Arasındaki İlişkinin İncelenmesi
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2008 - 2009
2008 - 2009Kan Plazmasında Serbest DNA Miktarı PCR'da Çoğaltılan Fragment Büyüklüğüne Göre Değişiyor mu?
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2007 - 2009
2007 - 2009
Kanserli Hastaların Serumlarında Serbest DNA Bütünlüğünün Kantitatif Real-Time PCR ile İncelenmesi
Project Supported by Higher Education Institutions
GEZER U. (Executive)
2007 - 2009
2007 - 2009LightCyCler PCR Yöntemi ile Kantitatif Metilasyon Analizinde Floresan Prob ve SYBR Green Yaklaşımlarının Karşılaştırılması
Project Supported by Higher Education Institutions
GEZER U. (Executive)
Memberships / Tasks in Scientific Organizations
2009 - Continues
2009 - ContinuesTıbbi Biyoloji ve Genetik derneği
Member
Scientific Refereeing
September 2015
September 2015TUBITAK Project
August 2015
August 2015Clinical Genetics
National Scientific Refreed Journal
May 2015
May 2015TUBITAK Project
April 2015
April 2015Tumor Biology
SCI Journal
March 2013
March 2013Clinica Chimica Acta
SCI Journal
March 2013
March 2013Clinical Biochmeistry
SCI Journal
February 2013
February 2013Tumor Biology
SCI Journal
December 2012
December 2012Tumor Biology
SCI Journal
July 2012
July 2012Clinica Chimica Acta
SCI Journal
May 2012
May 2012Clinica Chimica Acta
SCI Journal
April 2012
April 2012Clinical Biochemistry
SCI Journal
February 2012
February 2012Clinica Chimica Acta
SCI Journal
January 2012
January 2012Clinica Chimica Acta
SCI Journal
June 2011
June 2011Clinica Chimica Acta
SCI Journal
February 2011
February 2011BMC Cancer
SCI Journal
Scientific Consultations
2013 - 2015
2013 - 2015Project Consultancy
TÜBİTAK
Istanbul University, Onkoloji Enstitüsü, Onkoloji, Turkey
2012 - 2015
2012 - 2015Project Consultancy
PADOVA Universitesi
Istanbul University, Onkoloji Enstitüsü, Onkoloji, Turkey
2010 - 2015
2010 - 2015Project Consultancy
TÜBİTAK
Istanbul University, Onkoloji Enstitüsü, Onkoloji, Turkey
Congress and Symposium Activities
01 October 2015 - 01 October 2015
01 October 2015 - 01 October 2015Circulating nucleic acids in serum and plasma
Attendee
Berlin-Germany
01 September 2014 - 01 September 2014
01 September 2014 - 01 September 2014Congress of Anticancer Research
Attendee
Thessaloníki-Greece
01 March 2014 - 01 March 2014
01 March 2014 - 01 March 201441h Congress of International Society of Oncology and Biomarkers
Attendee
Barcelona-Spain
01 October 2012 - 01 October 2012
01 October 2012 - 01 October 2012. 40th Congress of International Society of Oncology and Biomarkers
Attendee
Yerushalayim-Israel
01 October 2011 - 01 October 2011
01 October 2011 - 01 October 20117th International Conference on Circulating Nucleic Acids in Plasma and Serum
Attendee
Madrid-Spain
01 October 2010 - 01 October 2010
01 October 2010 - 01 October 201038th Congress of International Society of Oncology and Biomarkers
Attendee
München-Germany
01 November 2009 - 01 November 2009
01 November 2009 - 01 November 20096th International Conference on Circulating Nucleic Acids in Plasma and Serum
Attendee
-Hong Kong
01 April 2009 - 01 April 2009
01 April 2009 - 01 April 2009AACR Annual Meeting
Attendee
Colorado-United States Of America
01 August 2007 - 01 August 2007
01 August 2007 - 01 August 2007